1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 32; p. S1132
Main Authors Salgia, S.K., Malhotra, J., Zengin, Z., Meza, L., Ely, J., Hsu, J., Kelley, E., Chehrazi-Raffle, A., Govindarajan, A., Muddasani, R., Salgia, N., Dizman, N., Chawla, N., Dorff, T., Lyou, Y., Karczewska, E., Trent, J., Salgia, R., Altin, J., Pal, S.K.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2021
European Society for Medical Oncology. Published by Elsevier Ltd
Online AccessGet full text

Cover

Author Hsu, J.
Salgia, N.
Dorff, T.
Lyou, Y.
Karczewska, E.
Salgia, R.
Altin, J.
Salgia, S.K.
Chehrazi-Raffle, A.
Dizman, N.
Govindarajan, A.
Muddasani, R.
Chawla, N.
Kelley, E.
Malhotra, J.
Zengin, Z.
Trent, J.
Pal, S.K.
Ely, J.
Meza, L.
Author_xml – sequence: 1
  givenname: S.K.
  surname: Salgia
  fullname: Salgia, S.K.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 2
  givenname: J.
  surname: Malhotra
  fullname: Malhotra, J.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 3
  givenname: Z.
  surname: Zengin
  fullname: Zengin, Z.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 4
  givenname: L.
  surname: Meza
  fullname: Meza, L.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 5
  givenname: J.
  surname: Ely
  fullname: Ely, J.
  organization: Pathogen Genomics and Integrated Cancer Genomics Divisions, Translational Genomics Research Institute, Flagstaff, AZ, USA
– sequence: 6
  givenname: J.
  surname: Hsu
  fullname: Hsu, J.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 7
  givenname: E.
  surname: Kelley
  fullname: Kelley, E.
  organization: Pathogen Genomics and Integrated Cancer Genomics Divisions, Translational Genomics Research Institute, Flagstaff, AZ, USA
– sequence: 8
  givenname: A.
  surname: Chehrazi-Raffle
  fullname: Chehrazi-Raffle, A.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 9
  givenname: A.
  surname: Govindarajan
  fullname: Govindarajan, A.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 10
  givenname: R.
  surname: Muddasani
  fullname: Muddasani, R.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 11
  givenname: N.
  surname: Salgia
  fullname: Salgia, N.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 12
  givenname: N.
  surname: Dizman
  fullname: Dizman, N.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 13
  givenname: N.
  surname: Chawla
  fullname: Chawla, N.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 14
  givenname: T.
  surname: Dorff
  fullname: Dorff, T.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 15
  givenname: Y.
  surname: Lyou
  fullname: Lyou, Y.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 16
  givenname: E.
  surname: Karczewska
  fullname: Karczewska, E.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 17
  givenname: J.
  surname: Trent
  fullname: Trent, J.
  organization: Genetic Basis of Human Disease Division, Translational Genomics Research Institute, Phoenix, AZ, USA
– sequence: 18
  givenname: R.
  surname: Salgia
  fullname: Salgia, R.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
– sequence: 19
  givenname: J.
  surname: Altin
  fullname: Altin, J.
  organization: Pathogen Genomics and Integrated Cancer Genomics Divisions, Translational Genomics Research Institute, Flagstaff, AZ, USA
– sequence: 20
  givenname: S.K.
  surname: Pal
  fullname: Pal, S.K.
  organization: Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
BookMark eNqFkdFq2zAUhsXoYGm3RxjoMrmwd2RZsXWzUdytK3QERrpbIUtyopBKnqRkdC_VV6yMx2BXuxI65_yfjv7_El047wxC7wmUBMj6w6GULpdUWUFFSmhLwljzCi0IW_OihZpcoAXwihYNo_UbdBnjAQDWvOIL9JyH6m8b3O1lkCqZYH_LZL3DfsDd5sfdTUE4PkulrJvrwcTRu2hw_4SlS7b3-gkvr_sVTjbLc03jbaHM8ZhHlRmTD3i57b6vcDQ_T8Zl0A5bh8eMMy5FvBxTXOFfNu2x1GfplNF4Z5xN_hTyoyHTbx9WWE2dEN-i14M8RvPuz3mFHr583nZfi_vN7V13fV-oCuqmaGvZKBgIV4xLxiSFgREYFGt6zZrK9A0MFWPQ9rTPd4DBVE0rK64bqinl9Ap9nLnjqX80WuVVgzyKMdjHvJLw0op_O87uxc6fRVuzmvIJwGaACj7GYIa_WgJiik0cxBybmGIT0Ioptqz7NOtM_t3ZmiCiykZlV2z2Mwnt7X8ILxKFppQ
ContentType Journal Article
Copyright 2021 European Society for Medical Oncology
Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2021 European Society for Medical Oncology
Copyright_xml – notice: 2021 European Society for Medical Oncology
– notice: Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2021 European Society for Medical Oncology
DBID AAYXX
CITATION
5PM
DOI 10.1016/j.annonc.2021.08.1557
DatabaseName CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1569-8041
EndPage S1132
ExternalDocumentID 10_1016_j_annonc_2021_08_1557
S0923753421037868
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6J9
70D
AABJS
AABMN
AAEDW
AAESY
AAIAV
AAIYJ
AAJKP
AAJQQ
AAKAS
AAKUH
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACIMA
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEIU
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFIYH
AFOFC
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AIKOY
AITUG
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASMCH
ASPBG
ATTQO
AVWKF
AWCFO
AXUDD
AZFZN
AZQFJ
BAWUL
BAYMD
BEYMZ
BGNMA
BGYMP
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CASEJ
CDBKE
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
DPORF
DPPUQ
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KC5
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
0SF
AALRI
AAYXX
ADVLN
AEHUL
AFETI
AFJKZ
AFSHK
AKRWK
CITATION
H13
5PM
ID FETCH-LOGICAL-c2047-84a7c0f19c59a55a30f510fc57bd572eb70f25508b3b57200fe278a29d73d3393
IEDL.DBID ABVKL
ISSN 0923-7534
IngestDate Tue Sep 17 21:25:23 EDT 2024
Thu Sep 26 18:50:16 EDT 2024
Fri Feb 23 02:42:59 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2047-84a7c0f19c59a55a30f510fc57bd572eb70f25508b3b57200fe278a29d73d3393
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8454399
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8454399
crossref_primary_10_1016_j_annonc_2021_08_1557
elsevier_sciencedirect_doi_10_1016_j_annonc_2021_08_1557
PublicationCentury 2000
PublicationDate September 2021
2021-09-00
20210901
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: September 2021
PublicationDecade 2020
PublicationTitle Annals of oncology
PublicationYear 2021
Publisher Elsevier Ltd
European Society for Medical Oncology. Published by Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
– name: European Society for Medical Oncology. Published by Elsevier Ltd
SSID ssj0006929
Score 2.4121792
SourceID pubmedcentral
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Publisher
StartPage S1132
Title 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers
URI https://dx.doi.org/10.1016/j.annonc.2021.08.1557
https://pubmed.ncbi.nlm.nih.gov/PMC8454399
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWyAEUvRVc0XYI59GAfGEukJFJHR22SLmmA1g58E0iJRJSDbchugHxVfjFDkXLjQ1CgR26iwCFnod48EfIJo4jMoBtLMfjRNEl0TJWMOWVacy2M1VndsX3-zM6mybdZOtshRZ8L42CVQfd7nd5p61AzCqs5WjbN6HeEvgk62wlzqW4yk7tkn6H3i6dzf3x8-f3HRiFnOfOUe4xTN-BvIs_o-kjNMcx2XIas4_JE8yoeM1HbqMkHZujkOXkW_EcY-1d8QXbM_CV5ch6-kL8id46W5fwCig0Rs8-zhIWF4uLy62ca53CjKuzt61sPkjWgbwFXudGL-hYGYz2EjnEZ62qYUHe_j10dBmbRwmBS_BpCQGGj7YNmDoGgdQWD5Xo1BHe_Cz3AAHCXouZwF_uqxaefTodQuZZ29ZpMT75MijMafspAK-ZYHWSiRBXZOK_SXKWp4pHFY22rVOg6FcxoEVkMUyKJssZyFFnDhFQsrwWvOc_5G7KHK27eEhBZllsXslUYE0ailkbxmukkq-I8scwckKNeDuXSc2-UPSjtuvSCK53gykiWTnAHRPbSKrc2UYn24V9DxZZ0NxM6-u3tlnlz1dFwyyR1wdy7_5_0PXnqih6y9oHsrds_5iP6OGt9GPbwIdk9ncX3kzb8Rg
link.rule.ids 230,315,783,787,888,27581,27936,27937,45675
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdGJwGXaXyJMQbvwKE9ZE3sJHaOJTA61m4StNNukZ3YIju0VdpN2l_Fv8hz7BR6QEgc44848nPeV37vF0I-YBSRanRjAwx-VBDHKgqkiFhAlWKKa6PSqmX7vEzH8_jrTXKzR_KuFsbCKr3udzq91da-Zeh3c7iq6-H3EH0TdLZjakvdRCoekX30BnjSI_ujj9cXk61CTjPqKPcoC-yE34U8w9tTucAw23IZ0pbLE80r_5uJ2kVN_mGGzg7JgfcfYeQe8RnZ04vn5PHUfyF_QX5aWpbpFeRbImZXZwlLA_nV9fmnIMrgXpY42rU3DiSrQT0A7nKtltUD9EdqAC3jMrZVMAtsfh-HWgzMsoH-LP82AI_CRtsH9QI8Qesa-qvNegA2vwsdwADwlKLmsIl92eDdv8wHUNqeZv2SzM8-z_Jx4H_KEJTUsjqIWPIyNFFWJplMEslCg6-1KROuqoRTrXhoMEwJBcoar8PQaMqFpFnFWcVYxl6RHu64fk2Ap2lmbMhWYkwY8kpoySqq4rSMsthQfUROOzkUK8e9UXSgtNvCCa6wgitCUVjBHRHRSavYOUQF2od_TeU70t0uaOm3d3sW9Y-WhlvEiQ3m3vz_ou_Jk_FsOikm55cXx-Sp7XLwtbekt2nu9An6Oxv1zp_nX6Ap_kM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1564MO+Characterization+of+COVID-19+vaccination+response+by+antibody+%28Ab%29+titer+and+T-cell+receptor+%28TCR%29+sequencing+in+patients+%28pts%29+with+advanced+genitourinary+%28GU%29+cancers&rft.jtitle=Annals+of+oncology&rft.au=Salgia%2C+S.K.&rft.au=Malhotra%2C+J.&rft.au=Zengin%2C+Z.&rft.au=Meza%2C+L.&rft.date=2021-09-01&rft.issn=0923-7534&rft.volume=32&rft.spage=S1132&rft_id=info:doi/10.1016%2Fj.annonc.2021.08.1557&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_annonc_2021_08_1557
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon